Deep Track Capital »

Autolus Therapeutics Plc spon ads shares owned by Deep Track Capital

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $35M 15M 2.33
2023-06-30 $36M 15M 2.38
2023-03-31 $28M 15M 1.84
2022-12-31 $29M 15M 1.90
2022-03-31 $1.6M 383k 4.17

More positions owned by Deep Track Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Intra Cellular Therapies (ITCI)
Ionis Pharmaceuticals (IONS)
Guardant Health (GH)
Immunovant (IMVT)
Alkermes SHS (ALKS)
Dynavax Technologies Corp Com New (DVAX)
Structure Therapeutics Sponsored Ads (GPCR)
Pliant Therapeutics (PLRX)
Springworks Therapeutics (SWTX)
Axsome Therapeutics (AXSM)
Bicycle Therapeutics Sponsored Ads (BCYC)
Travere Therapeutics (TVTX)
Intellia Therapeutics (NTLA)

View all positions for Deep Track Capital

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads